COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-01525-0002-0000-7
Chemical Name: 5,5-Diphenylhydantoin (phenytoin)
CASRN: 57-41-0
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 335957_CA
Study Result: Negative

Study Result: Negative
Activation Trial Trial Call
No Activation  Negative 
Induced Rat Liver S9  1_S9  Negative 
Induced Rat Liver S9  2_S9  Negative 

Trial #:1   Activation: No Activation    Date: 08/13/1981    Harvest Time: 14 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 2 0.020 2.0 0 0.000 0.0 2 0.020 2.0 0 0.000 0.0
Test Chemical: 5,5-Diphenylhydantoin (phenytoin)
500         
100 3 0.030 3.0 1 0.010 1.0 2 0.020 2.0 0 0.000 0.0
1600         
100 2 0.020 2.0 0 0.000 0.0 2 0.020 2.0 0 0.000 0.0
5000         
100 2 0.020 2.0 1 0.010 1.0 1 0.010 1.0 0 0.000 0.0
Positive Control: Triethylenemelamine
 0.15      
100 31 0.310 24.0 10 0.100 9.0 21 0.210 19.0 0 0.000 0.0
Trend: -0.151 0.630 -0.510  
Probability: 0.560 0.264 0.695  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 09/10/1981    Harvest Time: 14 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 3 0.030 3.0 1 0.010 1.0 2 0.020 2.0 0 0.000 0.0
Test Chemical: 5,5-Diphenylhydantoin (phenytoin)
125         
100 4 0.040 4.0 1 0.010 1.0 3 0.030 3.0 0 0.000 0.0
250         
100 7 0.070 6.0 1 0.010 1.0 6 0.060 5.0 0 0.000 0.0
2500         
100 2 0.020 2.0 0 0.000 0.0 2 0.020 2.0 0 0.000 0.0
5000         
100 2 0.020 2.0 0 0.000 0.0 2 0.020 2.0 0 0.000 0.0
Positive Control: Cyclophosphamide
15         
100 20 0.200 18.0 11 0.110 11.0 9 0.090 8.0 0 0.000 0.0
Trend: -0.945 -1.326 -0.417  
Probability: 0.828 0.908 0.662  


Trial #:2_S9   Activation: Induced Rat Liver S9    Date: 08/13/1981    Harvest Time: 14 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Dimethyl Sulfoxide
0         
100 3 0.030 3.0 0 0.000 0.0 3 0.030 3.0 0 0.000 0.0
Test Chemical: 5,5-Diphenylhydantoin (phenytoin)
16         
100 5 0.050 5.0 2 0.020 2.0 3 0.030 3.0 0 0.000 0.0
50         
100 8 0.080 7.0 1 0.010 1.0 7 0.070 6.0 0 0.000 0.0
160         
100 8 0.080 8.0 1 0.010 1.0 7 0.070 7.0 0 0.000 0.0
Positive Control: Cyclophosphamide
15         
100 33 0.330 30.0 14 0.140 14.0 19 0.190 18.0 0 0.000 0.0
Trend: 1.632 0.450 1.576  
Probability: 0.051 0.326 0.058